These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 8946197)
1. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15. Silva S; Babonits M; Klein G Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197 [TBL] [Abstract][Full Text] [Related]
2. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations. Silva S; Wiener F; Klein G; Janz S Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495 [TBL] [Abstract][Full Text] [Related]
3. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas]. Ohno S Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577 [TBL] [Abstract][Full Text] [Related]
4. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda. Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673 [TBL] [Abstract][Full Text] [Related]
5. Chromosomal translocations deregulating c-myc are associated with normal immune responses. Roschke V; Kopantzev E; Dertzbaugh M; Rudikoff S Oncogene; 1997 Jun; 14(25):3011-6. PubMed ID: 9223664 [TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors. Klein G AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345 [TBL] [Abstract][Full Text] [Related]
7. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. Wiener F; Coleman A; Mock BA; Potter M Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005 [TBL] [Abstract][Full Text] [Related]
8. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma. Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586 [TBL] [Abstract][Full Text] [Related]
9. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations. Ohno S; Migita S; Murakami S Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771 [TBL] [Abstract][Full Text] [Related]
10. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping. Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573 [TBL] [Abstract][Full Text] [Related]
11. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation. McNeil N; Kim JS; Ried T; Janz S Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044 [TBL] [Abstract][Full Text] [Related]
12. High resolution banding analysis of the involvement of strain BALB/c- and AKR-derived chromosomes No. 15 in plasmacytoma-specific translocations. Wiener F; Babonits M; Bregula U; Klein G; Léonard A; Wax JS; Potter M J Exp Med; 1984 Jan; 159(1):276-91. PubMed ID: 6607313 [TBL] [Abstract][Full Text] [Related]
13. Translocation frequencies and chromosomal proximities for selected mouse chromosomes in primary B lymphocytes. Righolt CH; Wiener F; Taylor-Kashton C; Harizanova J; Vermolen BJ; Garini Y; Young IT; Mai S Cytometry A; 2011 Apr; 79(4):276-83. PubMed ID: 21387545 [TBL] [Abstract][Full Text] [Related]
14. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177 [TBL] [Abstract][Full Text] [Related]
15. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice. Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720 [TBL] [Abstract][Full Text] [Related]
16. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents. Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513 [TBL] [Abstract][Full Text] [Related]
17. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388 [TBL] [Abstract][Full Text] [Related]
18. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction. Müller JR; Jones GM; Potter M; Janz S Cancer Res; 1996 Jan; 56(2):419-23. PubMed ID: 8542601 [TBL] [Abstract][Full Text] [Related]
19. Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2. Walker MC; Phillips-Quagliata JM J Immunol; 1979 Apr; 122(4):1535-43. PubMed ID: 448097 [TBL] [Abstract][Full Text] [Related]